OBJECTIVE: To determine whether asthma control in Canada had improved since the last major survey in 1999 by exploring how well patients' asthma was controlled, how much they knew about asthma control, and how they used health care resources. DESIGN: National telephone survey of patients between April and August 2004. SETTING: Canada. PARTICIPANTS: Eight hundred ninety-three adults 18 to 54 years old diagnosed with asthma more than 6 months before the survey. MAIN OUTCOME MEASURES: Patients' control of their asthma, patients' knowledge about asthma, the frequency and duration of periods of worsening asthma, and patients' use of health care resources to manage those periods. RESULTS: In total, 26,210 households listed in a consumer database were contacted. Excluding ineligible households and households with a language barrier, a member of 13% of the households completed the 35-minute survey. Based on definitions in Canadian guidelines, 53% of patients had symptomatic uncontrolled asthma. In the previous year, almost all asthma patients had experienced worsening of symptoms that lasted on average 13.6 days for patients with uncontrolled asthma and 8.0 days for patients with controlled asthma (P < .02). Markedly more patients with uncontrolled asthma used health care resources for episodes of asthma than patients with controlled asthma did (72% vs 15% for urgent office visits, P < .01; 32% vs 3% for emergency department visits, P < .01; and 7% vs 0% for hospitalizations, P < .01) in the year before the survey. Patients were confused about the differences between reliever and controller medications. One third of patients claimed that no one had taught them about asthma medications, and one quarter said they had received no training on how to recognize the early signs of asthma worsening. CONCLUSION: Asthma control and management remained suboptimal in Canada and relatively unchanged since the previous major survey in 1999.
OBJECTIVE: To determine whether asthma control in Canada had improved since the last major survey in 1999 by exploring how well patients' asthma was controlled, how much they knew about asthma control, and how they used health care resources. DESIGN: National telephone survey of patients between April and August 2004. SETTING: Canada. PARTICIPANTS: Eight hundred ninety-three adults 18 to 54 years old diagnosed with asthma more than 6 months before the survey. MAIN OUTCOME MEASURES: Patients' control of their asthma, patients' knowledge about asthma, the frequency and duration of periods of worsening asthma, and patients' use of health care resources to manage those periods. RESULTS: In total, 26,210 households listed in a consumer database were contacted. Excluding ineligible households and households with a language barrier, a member of 13% of the households completed the 35-minute survey. Based on definitions in Canadian guidelines, 53% of patients had symptomatic uncontrolled asthma. In the previous year, almost all asthmapatients had experienced worsening of symptoms that lasted on average 13.6 days for patients with uncontrolled asthma and 8.0 days for patients with controlled asthma (P < .02). Markedly more patients with uncontrolled asthma used health care resources for episodes of asthma than patients with controlled asthma did (72% vs 15% for urgent office visits, P < .01; 32% vs 3% for emergency department visits, P < .01; and 7% vs 0% for hospitalizations, P < .01) in the year before the survey. Patients were confused about the differences between reliever and controller medications. One third of patients claimed that no one had taught them about asthma medications, and one quarter said they had received no training on how to recognize the early signs of asthma worsening. CONCLUSION:Asthma control and management remained suboptimal in Canada and relatively unchanged since the previous major survey in 1999.
Authors: L P Boulet; T R Bai; A Becker; D Bérubé; R Beveridge; D M Bowie; K R Chapman; J Côté; D Cockcroft; F M Ducharme; P Ernst; J M FitzGerald; T Kovesi; R V Hodder; P O'Byrne; B Rowe; M R Sears; F E Simons; S Spier Journal: Can Respir J Date: 2001 Mar-Apr Impact factor: 2.409
Authors: Christopher K W Lai; Teresita S De Guia; You-Young Kim; Sow-Hsong Kuo; Amartya Mukhopadhyay; Joan B Soriano; Pham Long Trung; Nan Shan Zhong; Norzila Zainudin; B M Z Zainudin Journal: J Allergy Clin Immunol Date: 2003-02 Impact factor: 10.793
Authors: Catherine Lemière; Tony Bai; Meyer Balter; Charles Bayliff; Allan Becker; Louis-Philippe Boulet; Dennis Bowie; André Cartier; Andrew Cave; Kenneth Chapman; Robert Cowie; Stephen Coyle; Donald Cockcroft; Francine M Ducharme; Pierre Ernst; Shelagh Finlayson; J Mark FitzGerald; Frederick E Hargreave; Donna Hogg; Alan Kaplan; Harold Kim; Cheryle Kelm; Paul O'Byrne; Malcolm Sears; Andrea White Markham Journal: Can Respir J Date: 2004 May-Jun Impact factor: 2.409
Authors: Meyer Balter; Pierre Ernst; Wade Watson; Harold Kim; Lisa Cicutto; Marie-France Beauchesne; Andrew J Cave; Alan Kaplan; Donna Hogg; Andrew McIvor; Tom Smiley; Michel Rouleau; J Mark FitzGerald Journal: Can Respir J Date: 2008 Nov-Dec Impact factor: 2.409
Authors: Helena Klomp; Joshua A Lawson; Donald W Cockcroft; Benjamin T Chan; Paul Cascagnette; Laurie Gander; Derek Jorgenson Journal: CMAJ Date: 2008-04-08 Impact factor: 8.262
Authors: Francine M Ducharme; Alexandrine J Lamontagne; Lucie Blais; Roland Grad; Kim L Lavoie; Simon L Bacon; Martha L McKinney; Eve Desplats; Pierre Ernst Journal: Can Respir J Date: 2016-06-15 Impact factor: 2.409